Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer

In estrogen receptor positive (ER+) breast cancer therapy, estrogen receptors (ERs) are the major targeting molecules. ER-targeted therapy has provided clinical benefits for approximately 70% of all breast cancer patients through targeting the ERα subtype. In recent years, mechanisms underlying brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Song, Lin, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Screening, Diagnosis, and Treatment of Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036337/
https://www.ncbi.nlm.nih.gov/pubmed/35450488
http://dx.doi.org/10.1177/15330338221090351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036337/
https://www.ncbi.nlm.nih.gov/pubmed/35450488
http://dx.doi.org/10.1177/15330338221090351

Ejemplares similares